Antibody-drug conjugates (ADCs) have fundamentally transformed the landscape of modern oncology, evolving from a theoretical "magic bullet" concept into a…
Read More
Gilead and Nucleai probe why target-positive tumors can still resist ADCs
Antibody-drug conjugates (ADCs) have fundamentally transformed the landscape of modern oncology, offering a sophisticated "seek-and-destroy" mechanism that couples the precision…
Read More
Immature Neurons and the Secret to Cognitive Resilience: New Research Explains Why Some Brains Resist Alzheimer’s Disease
The scientific community has long grappled with a biological paradox: why do some individuals maintain perfect mental clarity until the…
Read More
Why tumors resist immunotherapy: how removing their armor can turn cold cancers hot
A groundbreaking study conducted by researchers at the University of California San Diego (CA, USA) has pinpointed microRNA-25 (miR-25) as…
Read MoreYOU MAY HAVE MISSED
